Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

Stefan Balabanov; Artur Gontarewicz; Patrick Ziegler; Ulrike Hartmann; Winfried Kammer; Mhairi Copland; Ute Brassat; Martin Priemer; Ilona Hauber; Thomas Wilhelm

doi:10.1182/blood-2005-03-037648

Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

Identifier:nobleid.org/w1/20260515/69697C71

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/69697C71.svg?ark=w1%2F20260515%2F69697C71)](https://nobleid.org/work/w1/20260515/69697C71)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

Identifier:nobleid.org/w1/20260515/69697C71

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/69697C71.svg?ark=w1%2F20260515%2F69697C71)](https://nobleid.org/work/w1/20260515/69697C71)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work